CIK 0001444192
- Non-accelerated filer
- Smaller reporting company
Grace Therapeutics, Inc.
Sign in to watch- Ticker
- GRCE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Mar 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 609-322-1602
- Business address
- 103 CARNEGIE CENTER, SUITE 300, PRINCETON, NJ, 08540
- Former names
- Acasti Pharma Inc.
- Open-market buys, last 90 days
- $898,410
- in 12 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$898,410. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-08-28 | Kumar Amresh VP Program Management | Grant or award · Stock Option (Right to Buy) | +35,760 | 35,760 | ||
| 2025-04-14 | Kumar Amresh VP Program Management | Grant or award · Stock Option (Right to Buy) | +30,000 | 30,000 | ||
| 2024-05-06 | Kumar Amresh VP Program Management | Grant or award · Stock Options (Right to Buy) | +19,740 | 19,740 | ||
| 2024-05-06 | Kumar Amresh VP Clinical Operations | Grant or award · Stock Options (Right to Buy) | +19,740 | 19,740 | ||
| 2023-07-14 | Kumar Amresh VP Program Management | Grant or award · Stock Options (Right to Buy) | +42,000 | 42,000 |
Page 1 of 1 · 5 trades